Is the germ that causes periodontitis responsible for Alzheimer's disease, diabetes, heart attack and chronically inflamed joints? Recent research suggests this. Knowledge opens up completely new opportunities for scientists to combat common diseases. California's Cortexim Pharmaceuticals is currently testing a drug that will stop Alzheimer's disease.
Scientists focus on one known in the dental microbe: The bacterium "Porphyromonas gingivalis" predicts gum, periodontal and jaw diseases. Microbes can also play a role in Alzheimer's disease, cardiovascular disease, colon cancer, or inflammatory joints.
As Bild am Sontag reported, researchers have now been able to detect germs at various sites of disease in the body with new DNA methods. For example, in constricted coronary arteries, in the brains of Alzheimer's patients, in chronically inflamed areas, in diabetic patients, in colon cancer, and in mothers with premature birth. The rod-shaped bacterium is a hundred times smaller than the diameter of the hair.
Paradontitis germ in the brain of patients with Alzheimer's disease
One spring study confirms this finding. Researchers from the United States, Poland and Australia have found traces of germs in more than 90 percent of the brains of deceased Alzheimer's patients and in cerebrospinal fluid of living patients. Microbiology and studies author Jan Potemka said:
Porphyromonas gingivalis occurs in a variety of chronic inflammatory diseases. However, in Alzheimer's we are next to prove that the bacterium can cause disease.
Germ enters the bloodstream through the oral cavity
This is also supported by a test of mice whose oral cavities were infected with the bacterium. Microbes migrated to the brain and damaged Alzheimer's.
In humans, the germ passes through the oral cavity through minor injuries while eating, brushing your teeth or when using a blood thinner and spreads from there. According to Professor Thomas Koher, director of the Polyclinic for Tooth Conservation, Periodontics, Endodontics, about 14% of 40-year-olds and 40% of 70-year-olds in Germany suffer from periodontitis caused by the bacterium.
Good oral hygiene reduces the risk
Good oral hygiene is essential to combat Porphyromonas. "Particularly the cleaning of the interdental spaces significantly reduces the number of germs"Says Kocher. This will also have a positive effect on other chronic diseases in the body.
Thus, in diabetes after periodontal treatment, blood sugar levels drop.
Researchers are working on vaccinations and drugs
Researchers are currently working on a vaccine. Even the promises to fight the light-blue bacteria are promising, said immunologist Carolyn Genko of Tufts University (USA), a bacterium expert on Porphyromonas, Bams.
California's Cortixim is currently testing a drug that blocks the toxin produced by their Porphyromonas. It can be a long-awaited way to stop Alzheimer's and Coa.